Kobe University · University Hospital · 助教

Research keywordscongenital cytomegalovirus infection・maternal screening・Toxoplasma gondii infection・semi-nested PCR・IgG avidity index・fetal antiviral therapy・neurological outcomes・pregnancy with type 1 diabetes

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• 治療的頸管縫縮術後の妊娠34週未満早産に関連する因子の検討2025 · (一社)日本周産期・新生児医学会, 2025年05月, 日本周産期・新生児医学会雑誌, 61(1) (1), 100 - 106, 日本語
• 妊娠前Body Mass Index 30kg/m2以上の初産婦において経腟分娩成功に関連する因子の検討2025 · (一社)日本周産期・新生児医学会, 2025年05月, 日本周産期・新生児医学会雑誌, 61(1) (1), 114 - 119, 日本語
• 周産期感染症の最前線 先天性サイトメガロウイルス感染2023 · 日本産婦人科・新生児血液学会, 2023年03月, 日本産婦人科・新生児血液学会誌, 32(2) (2), 27 - 33, 日本語
• Clinical Practice Guidelines for the Management of Congenital Cytomegalovirus Infection in Japan 2023: Executive Summary.2023 · Congenital cytomegalovirus (cCMV) infection is the most common congenital infection in developed countries. Although a standard therapy has not yet been established, evidence for the management of cCMV infection has been accumulating. The first edition of the "Clinical Practice Guidelines for the Management of Congenital Cytomegalovirus Infection" was published in Japan in 2023. This summary outlines the clinical questions (CQs) in the guidelines, with reference to the Japanese Medical Information Distribution Service Manual. Overall, 20 CQs with statements regarding prenatal risk assessment, prevention and management at diagnosis (CQs 1-1-1-3), diagnosis (CQs 2-1-2-6), treatment (CQs 3-1-3-7) and follow-up requirements (CQs 4-1-4-4) have been discussed. For each statement, the levels of recommendation, evidence and consensus rates were determined. These guidelines will assist in the management of patients with cCMV infection.

• 先天性トキソプラズマ感染症におけるペア型レセプターを介した免疫逃避機構の解明

• Official profile